These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8741397)

  • 1. [Molecular genetics of apolipoprotein E and its receptors, implications for genetic risk factors of Alzheimer's disease].
    Okuizumi K; Tsuji S
    Tanpakushitsu Kakusan Koso; 1996 Aug; 41(10):1460-4. PubMed ID: 8741397
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apolipoprotein E4 and Alzheimer's disease].
    Mori S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():812-7. PubMed ID: 11347179
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibody against the polymorphic site distinguishes apolipoprotein E4 from other isoforms.
    Nukina N; Uchida K; Sakamoto T; Ide K; Kanazawa I
    Biochem Biophys Res Commun; 1995 Nov; 216(2):467-72. PubMed ID: 7488135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoE: new risk factor for Alzheimer's.
    Butler RN
    Geriatrics; 1994 Aug; 49(8):10-1. PubMed ID: 8039724
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alzheimer's disease and the association of genetic polymorphism of apolipoprotein E and liquor beta protein in Finns].
    Lehtimäki T; Pirttilä T; Frey H; Nikkari T
    Duodecim; 1995; 111(5):401-7. PubMed ID: 8674441
    [No Abstract]   [Full Text] [Related]  

  • 6. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples.
    Fallin D; Gauntlett AC; Scibelli P; Cai X; Duara R; Gold M; Crawford F; Mullan M
    Genet Epidemiol; 1997; 14(3):299-305. PubMed ID: 9181358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apolipoprotein E polymorphism in Alzheimer's disease].
    Shimohama S
    Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):173-7. PubMed ID: 8648892
    [No Abstract]   [Full Text] [Related]  

  • 8. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.
    Bullido MJ; Artiga MJ; Recuero M; Sastre I; García MA; Aldudo J; Lendon C; Han SW; Morris JC; Frank A; Vázquez J; Goate A; Valdivieso F
    Nat Genet; 1998 Jan; 18(1):69-71. PubMed ID: 9425904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator.
    Mutter J; Naumann J; Sadaghiani C; Schneider R; Walach H
    Neuro Endocrinol Lett; 2004 Oct; 25(5):331-9. PubMed ID: 15580166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4.
    Kim KW; Suh YJ; Park WY; Jhoo JH; Lee DY; Youn JC; Lee KH; Seo JS; Woo JI
    Neurosci Lett; 2004 Aug; 366(2):182-6. PubMed ID: 15276243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apolipoprotein E genotypes in patients investigated for dementia].
    Johannsen P; Jakobsen JK; Jørgensen AL
    Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
    Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
    J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease and genetic testing.
    Karlinsky H; Lennox A; Rossor M
    Alzheimer Dis Assoc Disord; 1994; 8(2):63-5; discussion 66-7. PubMed ID: 8060607
    [No Abstract]   [Full Text] [Related]  

  • 14. Dog from hell chases Alzheimer's.
    Brower V
    Nat Biotechnol; 1997 Apr; 15(4):311. PubMed ID: 9094117
    [No Abstract]   [Full Text] [Related]  

  • 15. [The Alzheimer-apoE4 connection].
    Jørgensen AL
    Ugeskr Laeger; 1993 Nov; 155(48):3936-7. PubMed ID: 8273205
    [No Abstract]   [Full Text] [Related]  

  • 16. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
    Laws SM; Clarnette RM; Taddei K; Martins G; Paton A; Hallmayer J; Almeida OP; Groth DM; Gandy SE; Förstl H; Martins RN
    Mol Psychiatry; 2002; 7(7):768-75. PubMed ID: 12192621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease.
    Lehmann DJ; Cortina-Borja M; Warden DR; Smith AD; Sleegers K; Prince JA; van Duijn CM; Kehoe PG
    Am J Epidemiol; 2005 Aug; 162(4):305-17. PubMed ID: 16033878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's disease.
    Manev H; Manev R
    Med Hypotheses; 2006; 66(3):501-3. PubMed ID: 16278051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme that detoxifies cancer drug linked to risk of Alzheimer's disease.
    Oncology (Williston Park); 1998 May; 12(5):777. PubMed ID: 9597686
    [No Abstract]   [Full Text] [Related]  

  • 20. Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease.
    Bullido MJ; Valdivieso F
    Microsc Res Tech; 2000 Aug; 50(4):261-7. PubMed ID: 10936877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.